SH2D2A
SH2 domain-containing protein 2A
Also known as: F2771, SH22A_HUMAN, TSAd
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NP31
- Gene
- SH2D2A
- Ensembl
- ENSG00000027869
- Chromosome
- 1
- Canonical length
- 389 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes an adaptor protein thought to function in T-cell signal transduction. A related protein in mouse is responsible for the activation of lymphocyte-specific protein-tyrosine kinase and functions in downstream signaling. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
Canonical amino-acid sequenceUniProt
389 residues, UniProt reviewed canonical sequence.
>Q9NP31|SH2D2A
1 MEFPLAQICP QGSHEAPIPT FSTFQITDMT RRSCQNLGYT AASPQAPEAA SNTGNAERAE
61 EVPGEGSLFL QAETRAWFQK TQAHWLLQHG AAPAWFHGFI TRREAERLLE PKPQGCYLVR
121 FSESAVTFVL TYRSRTCCRH FLLAQLRDGR HVVLGEDSAH ARLQDLLLHY TAHPLSPYGE
181 TLTEPLARQT PEPAGLSLRT EESNFGSKSQ DPNPQYSPII KQGQAPVPMQ KEGAGEKEPS
241 QLLRPKPPIP AKPQLPPEVY TIPVPRHRPA PRPKPSNPIY NEPDEPIAFY AMGRGSPGEA
301 PSNIYVEVED EGLPATLGHP VLRKSWSRPV PGGQNTGGSQ LHSENSVIGQ GPPLPHQPPP
361 AWRHTLPHNL SRQVLQDRGQ AWLPLGPPQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SH2D2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- thymus: 14 nTPM
- spleen: 13 nTPM
- appendix: 11 nTPM
- lymph node: 8.8 nTPM
- choroid plexus: 6.2 nTPM
- tonsil: 5.5 nTPM
Single-cell type
- nk-cells: 125 nCPM
- t-cells: 79 nCPM
- decidual stromal cells: 26 nCPM
- retinal bipolar cells: 24 nCPM
- innate lymphoid cells: 17 nCPM
- platelets: 9.8 nCPM
Immune cell
- gdT-cell: 67 nTPM
- MAIT T-cell: 62 nTPM
- memory CD8 T-cell: 41 nTPM
- T-reg: 34 nTPM
- NK-cell: 29 nTPM
- memory CD4 T-cell: 28 nTPM
Brain region
- cerebellum: 6.9 nTPM
- medulla oblongata: 2.8 nTPM
- choroid plexus: 2.7 nTPM
- pons: 2.1 nTPM
- hypothalamus: 2 nTPM
- white matter: 1.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.48
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SH2 domain
- SH2 domain superfamily
- SH2 domain
- SH2D2A, SH2 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SH2D2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SH2D2A as an antibody target. Whether an autoantibody or antibody against SH2D2A could matter depends on whether native SH2D2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SH2D2A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SH2D2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...